Khanna, IN
Amit Khanna, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20100152129 | Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer - Synergistic combinations of gemcitabine with P276-00 or P1446A and their use in the treatment of cancer are disclosed. The invention further describes novel and unique gene signatures comprising gene markers used to monitor the drug response in a subject treated with the said combinations. | 06-17-2010 |
20110312528 | Novel synergistic combination of gemcitabine with P276-00 or P1446A in treatment of cancer - Synergistic combinations of gemcitabine with P276-00 or P1446A and their use in the treatment of cancer are disclosed. The invention further describes novel and unique gene signatures comprising gene markers used to monitor the drug response in a subject treated with the said combinations. | 12-22-2011 |
Amit Khanna, Gurgaon IN
Patent application number | Description | Published |
---|---|---|
20120290353 | METHOD AND SYSTEM FOR AUTOMATIC CHANNEL OPTIMIZER - Systems and methods are described for determining an allocation of resources among a plurality of channels. In one embodiment, a business objective is received as user input that corresponds to a participant in a market or business sector. A business segment corresponding to the market participant's products or interests, one or more products within the business segment, and a market channel of the plurality of channels is selected by the user, also as user input. Once these inputs have been established, an high performing allocation resources for achieving the business objective is generated for that market channel. | 11-15-2012 |
Anurag Khanna, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20110078046 | ENHANCED SUPPLIER CATALOG COLLABORATION - One embodiment of the invention includes a computer-implemented method for supplier update of a procurement system. The method includes providing a customizable procurement entity to a supplier, receiving a modified procurement entity from the supplier, wherein the modified procurement entity comprises an update made by the supplier to the customizable procurement entity, reviewing and approving the modified procurement entity, and publishing the modified procurement entity to the procurement system. | 03-31-2011 |
Aparna Khanna, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090220996 | In vitro Assay Methods for Classifying Embryotoxicity of Compounds - The present disclosure provides methods useful for screening compounds and/or compositions, for example potential drug candidates. The results of the screening assays correlate to the effects of the compounds on the molecular and/or cellular level of the human body. Also disclosed are screening assays utilizing human embryonic stem cells RELICELL®hES of Indian origin. The methods disclosed herein correlate well with animal preclinical toxicity studies done in a clinical trial setup. | 09-03-2009 |
Gollapalli Bhasker Ramesh Khanna, Hyderabad IN
Patent application number | Description | Published |
---|---|---|
20090233337 | Chemoenzymatic Process for the Stereoselective Preparation of (R)-Gamma-Amino-Beta-Hydroxybutyric Acid [(R)-GABOB) and (R)-Carnitine - The present invention provides a chemoenzymatic process for the preparation of (R)-GABOB and (R)-carnitine employing lipase-mediated resolution of 3-hydroxy-4-tosyloxybutanenitrile as the key step. The drawing accompanying this specification represents the preparation of racemic 3-hydroxy-4-tosyloxybutanenitrile, its lipase-mediated kinetic resolution and its successful application in the preparation of (R)-GABOB and (R)-carnitine. | 09-17-2009 |
Gorev Khanna, Uttar Pradesh IN
Patent application number | Description | Published |
---|---|---|
20110312305 | System and Method for Provisioning Social Networking Services Through Ring Back Tones - A method and system for provisioning of social networking services through ring back tones is provided. In various embodiments of the present invention, when a caller makes a call to a callee, a ring back tone containing social network profile information is provided to the caller. | 12-22-2011 |
Jag Mohan Khanna, Kumar IN
Patent application number | Description | Published |
---|---|---|
20090137812 | PROCESS FOR PRODUCING 1-BENZYL-4-[5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE OR ITS SALT THEREOF VIA NOVEL INTERMEDIATE - Disclosed herein the process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2yl)methyl]piperidine or its salt thereof employing novel intermediates. | 05-28-2009 |
Mahavir Singh Khanna, Delhi IN
Patent application number | Description | Published |
---|---|---|
20080275245 | Processes for the Preparation of Substituted Sulfoxides - The present invention relates to a process for enantioselective synthesis of substituted pyridinylmethyl sulfinyl-benzimidazole of compound of Formula (I). The process includes enantioselective catalytic oxidation of a substituted pyridinylmethyl prochiral sulfide derivative of compound of Formula (II) with an oxidizing agent in the presence of a chiral transition metal complex and a base in the absence of an organic solvent. | 11-06-2008 |
20100145058 | BARIUM SALT OF BENZIMIDAZOLE DERIVATIVE - The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared. | 06-10-2010 |
Mahavir Singh Khanna, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20090259047 | BARIUM SALT OF BENZIMIDAZOLE DERIVATIVE - The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared. | 10-15-2009 |
20100137607 | BARIUM SALT OF BENZIMIDAZOLE DERIVATIVE - The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)- | 06-03-2010 |
20110086884 | BARIUM SALT OF BENZIMIDAZOLE DERIVATIVE - The invention relates to crystalline barium salt of (S)-omeprazole, which is (S)-5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole. The invention also relates to processes for preparing crystalline barium salt of (S)-omeprazole and pharmaceutical compositions that include the crystalline barium salt of (S)-omeprazole so prepared. | 04-14-2011 |
20110178305 | PROCESS FOR THE PREPARATION OF 3,4-EPOXY-2-AMINO-1-SUBSTITUTED BUTANE DERIVATIVES AND INTERMEDIATE COMPOUNDS THEREOF - The present invention relates to a process for the preparation of threo-3,4-epoxy-2-amino-1-substituted butane derivatives represented by general Formula I which comprises reacting compound of Formula III or salt thereof with an active ester of acid of Formula IV and treating the product thereof with base. The carbon atom bonded to the radical R | 07-21-2011 |
20120190849 | PROCESSES FOR THE PREPARATION OF VARDENAFIL - The present invention provides processes for the preparation of vardenafil, its pharmaceutically acceptable salts, hydrates and intermediates. | 07-26-2012 |
20120283440 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation.(FORMULA) | 11-08-2012 |
20130197232 | PROCESS FOR THE PREPARATION OF CRYSTALLINE FORMS OF DEXLANSOPRAZOLE - The present invention relates to crystalline forms of dexlansoprazole designated as forms A and B, and their preparation. The present invention further relates to processes for the preparation of anhydrous dexlansoprazole and dexlansoprazole sesquihydrate using crystalline Forms A and B of dexlansoprazole. | 08-01-2013 |
20130197233 | SALTS OF DEXLANSOPRAZOLE AND THEIR PREPARATION - The present invention relates to the salts of dexlansoprazole in amorphous form. The present invention further relates to processes for the preparation of salts of dexlansoprazole. | 08-01-2013 |
20130204002 | PROCESS FOR THE PREPARATION OF DEXLANSOPRAZOLE - The present invention relates to a process for the preparation of crystalline dexlansoprazole. | 08-08-2013 |
20140187568 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation. | 07-03-2014 |
20140187569 | CRYSTALLINE FORMS OF BOSENTAN SALTS AND PROCESSES FOR THEIR PREPARATION - The present invention relates to crystalline forms of bosentan salts and processes for their preparation. | 07-03-2014 |
20140336380 | PROCESS FOR THE PREPARATION OF AGOMELATINE | 11-13-2014 |
20140343290 | PROCESS FOR THE PREPARATION OF ATAZANAVIR OR ITS BISULFATE SALT - The present invention relates to an improved process for the preparation of atazanavir bisulfate, an inhibitor of retroviral aspartate protease. The process of the present invention comprises conversion of 1,1-dimethylethyl[(2S,3R)-4-chloro-3-hydroxy-phenylbutan-2-yl]carbamate (Formula II) into 1-[4-(pyridine-2-yl)-phenyl]-4(S)-5 hydroxy-2-N-tert-butoxycarbonylamino-5(S)—N—(N-methoxycarbonyl-(L)-tert-leucyl)amino-6-phenyl-2-azahexane (Formula VII) without isolating intermediate compounds formed therein, followed by its subsequent conversion to atazanavir or its bisulfate salt. | 11-20-2014 |
20140357870 | PROCESS FOR THE PREPARATION OF DEXLANSOPRAZOLE - The present invention relates to a process for the preparation of dexlansoprazole.xH | 12-04-2014 |
20150111940 | ASCORBIC ACID SALT OF SUNITINIB - The present invention relates to an ascorbic acid salt of sunitinib and a process for its preparation. The present invention further provides a crystalline Form I of an L-ascorbic acid salt of sunitinib. | 04-23-2015 |
20150112085 | PURE CRYSTALLINE FORM II OF L-MALIC ACID SALT OF SUNITINIB AND PROCESSES FOR ITS PREPARATION - The present invention relates to pure crystalline Form II of an L-malic acid salt of sunitinib and a process for its preparation. The invention further provides crystalline Form II of an L-malic acid salt of sunitinib having a purity of at least 97.0%. The invention also provides crystalline Form II of an L-malic acid salt of sunitinib substantially free of an anti-oxidant. The invention also provides crystalline Form II of L-malic acid salt of sunitinib which remains chemically pure on storage at 25° C.±2° C. and 40° C.±2° C. at a relative humidity of 60%±5% and 75%±5%, respectively, for at least 1 month. | 04-23-2015 |
Mahivir Singh Khanna, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20080312254 | Process for the Preparation of Ziprasidone - The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia. | 12-18-2008 |
20110207933 | PROCESS FOR THE PREPARATION OF ZIPRASIDONE - The invention relates to processes for the preparation of substantially pure ziprasidone. The invention also relates to the preparation of acid addition salts of ziprasidone. More particularly, it relates to the preparation of substantially pure hydrochloride salt of ziprasidone. The invention also relates to pharmaceutical compositions that include the substantially pure ziprasidone or ziprasidone hydrochloride and use of said compositions for treating schizophrenia. | 08-25-2011 |
Manish Khanna, Agra IN
Patent application number | Description | Published |
---|---|---|
20110288830 | Finite State Machine Diagram Generation - A method for processing machine information of a system, such as an integrated circuit design, to generate a display of a finite state machine diagram by determining a position for the states in the diagram and then showing representations of the transitions between states to create a symmetrical, compact and cyclic process view of the finite state machine. Levels are assigned to the states in a first direction. A rule based technique then is used to order the states in levels that ensure minimum crossings of transitions between consecutive levels as well as for transitions in a same level. Next, the specific position of each state in a second direction orthogonal to the first direction is computed, such that the positions take into account areas or “tracks” in which connection lines representing transitions between states will be rendered. The connection line representing transitions between states are then rendered in the diagram. | 11-24-2011 |
Nandoo Mal Khanna, Uttar Pradesh IN
Patent application number | Description | Published |
---|---|---|
20100093870 | HERBAL MEDICAMENTS FOR THE TREATMENT OF NEUROCEREBROVASCULAR DISORDERS - The present invention relates to A composition obtained from the lipid soluble extract of rhizomes and leaves of | 04-15-2010 |
Navin Khanna, New Delhi IN
Patent application number | Description | Published |
---|---|---|
20100145025 | Recombinant Mouse-Human Chimeric Fab Against Hepatitis B Surface Antigen - The invention relates to a recombinant chimeric Fab antibody comprising a recombinant Fd and a recombinant chimeric light chain which binds to hepatitis B surface antigen with high affinity, generated by fusing variable region genes (V | 06-10-2010 |
20110046354 | Humanized High Affinity Recombinant Antibody Against Hepatitis B Surface Antigen - This invention relates to a high affinity recombinant humanized antibody fragment (scFv) specific for hepatitis B surface antigen having unique inter/intra chain bonding interaction because of 28 altered amino acid residues from the original mouse (5S) antibody and its chimeric Fab form, wherein fine tuning of the vernier zone residue makes it closer to the human sequence without any structural constraints. | 02-24-2011 |
20120107424 | ANTI DENGUE ACTIVITY OF CISSAMPELOS PAREIRA EXTRACTS - The present invention relates to the anti dengue activity of the | 05-03-2012 |
Nitin Khanna, Dehradun IN
Patent application number | Description | Published |
---|---|---|
20160044025 | SYSTEM AND METHOD FOR SECURITY ENHANCEMENT - A system and method thereof for secure authentication using multimedia contents set particular to user (MCSPU) and user specified parameters is disclosed. A host system for performing an authentication with a user system is disclosed. The host system comprises of a processor; and a memory coupled to said processor for executing a plurality of modules present in said memory. For the authentication (while logging in or performing a transaction), the host system would provide to the user one or more elements belonging to MCSPU, after embedding, within the elements the authentication related critical information using the user specific parameters. The proposed method ensures the user that the response is coming from authentic system. In case of suspicious user behavior, the parameters or multimedia contents not specific to the user could be used. | 02-11-2016 |
Nitin Khanna, Delhi IN
Patent application number | Description | Published |
---|---|---|
20100095339 | Method and apparatus for designing a communication mechanism between embedded cable modem and embedded set-top box - The present disclosure discloses a digital communication between the between embedded cable modem (eCM) and embedded set-top box (eSTB) via a shared memory. The communication is carried out by packet transfer mechanism as per the protocol without adding any extra header overhead. The communication link is established between the eSTB and eCM mainly in layer 2 and partly in layer 1 according to an implementation of the OSI model. Further, eSTB is used as an eSAFE device coupled to eCM where the eCM and eSTB are considered to be placed on two SoCs with a separate CPU to each SoC (System-On-Chip) with a shared memory (via high speed data bus protocol). DMA (Direct Memory Access) engines are used to accelerate data transfer and to reduce load. DMA of only eCM, SoC is used to minimize hardware resources. | 04-15-2010 |
Pankaj Khanna, Delhi IN
Patent application number | Description | Published |
---|---|---|
20110229591 | WITHANIA SOMNIFERA PLANT EXTRACT AND METHOD OF PREPARATION THEREOF - The present invention provides | 09-22-2011 |
Prateek Khanna, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20100287418 | DIAGNOSTIC SOLUTION FOR WEB SERVICE PROCESS FLOWS - The embodiments presented herein provide systems, methods, and data structures for troubleshooting particular SOAP-based web service process flow. The SOAP request can be modified to include a diagnostic request in the SOAP request. Upon receiving the SOAP request, the application server can log actions related to the SOAP-based web service into the header of the SOAP response. The application server can complete the SOAP-based web service and send the SOAP response to the user. The user can then be presented with the logging in the header to facilitate the diagnosis of problems with the web service. Without causing unneeded logging at the application server, the present embodiments allow a user to diagnose and test web services. | 11-11-2010 |
20120331018 | SYSTEM AND METHOD FOR USE WITH GARBAGE COLLECTED LANGUAGES FOR ENABLING THE ALLOCATED HEAP MEMORY TO BE UPDATED AT RUNTIME - A system and method for use with garbage collected systems and languages, for enabling an allocated heap memory to be updated (e.g., increased or decreased) at runtime, subject to sufficient availability of physical memory. In accordance with an embodiment, a Java Virtual Machine (JVM) is associated with a management console, which allows a systems administrator to monitor current heap utilization at runtime. The heap is visualized as a contiguous chunk of memory with one or more extension points, e.g., by use of a trailing pointer to a null list. If later, at runtime, the heap size needs to be incremented then the trailing pointer can be set to a new chunk of memory with a size of (new value−old value), so that the cumulative new size is made equal to a new value specified on the console. The new chunk of memory can again end with a trailing pointer, to allow for further extension. The features can help ensure that an alert administrator will have the means to prevent an out-of-memory situation when the allocated heap proves insufficient at runtime. | 12-27-2012 |
20130304771 | SYSTEM AND METHOD FOR USE WITH GARBAGE COLLECTED LANGUAGES FOR ENABLING THE ALLOCATED HEAP MEMORY TO BE UPDATED AT RUNTIME - A system and method for use with garbage collected systems and languages, for enabling an allocated heap memory to be updated (e.g., increased or decreased) at runtime, subject to sufficient availability of physical memory. In accordance with an embodiment, a Java Virtual Machine (JVM) is associated with a management console, which allows a systems administrator to monitor current heap utilization at runtime. The heap is visualized as a contiguous chunk of memory with one or more extension points, e.g., by use of a trailing pointer to a null list. If later, at runtime, the heap size needs to be incremented then the trailing pointer can be set to a new chunk of memory with a size of (new value−old value), so that the cumulative new size is made equal to a new value specified on the console. | 11-14-2013 |
Rajesh Khanna, Gurgaon IN
Patent application number | Description | Published |
---|---|---|
20140378407 | PROCESS FOR PREPARING STABLE PHARMACEUTICAL COMPOSITIONS OF COMPOUNDS SUSCEPTIBLE TO HYDROLYSIS - The present invention relates to a process of preparing a stable pharmaceutical composition of compounds which are susceptible to hydrolysis comprising a. Addition of required quantity of pharmaceutically acceptable lyophilization excipients optionally in Water for Injection in a formulation vessel; b. Addition of organic solvent to form a appropriate proportion of aqueous and organic solvent; c. Maintaining the temperature of the formulation vessel from the range −5±1° C. to −5±3° C.; d. Addition of required quantity of compound susceptible to hydrolysis to form a solution and lyophilizing the solution. | 12-25-2014 |
20150073000 | STABLE READY-TO-USE PHARMACEUTICAL COMPOSITION OF PEMETREXED - A stable ready-to-use pharmaceutical composition comprising pemetrexed or pharmaceutically acceptable salts thereof, wherein the composition is free from antioxidants, amino acids and chelating agents. Also provided is a process for preparing a stable ready-to-use pharmaceutical composition comprising the steps: i) purging inert gas into a parenterally acceptable aqueous solvent until the dissolved oxygen content of the solvent comes to less than 7 mg/L, preferably less than 3 mg/L; ii) adding pemetrexed disodium under stirring; iii) adjusting the pH of the resulting solution to between 4 to 9; iv) optionally adding additional aqueous solvent; wherein the composition is purged with inert gas throughout the entire process. | 03-12-2015 |
Rajesh Khanna, Haryana IN
Patent application number | Description | Published |
---|---|---|
20110301189 | STABLE PHARMACEUTICAL COMPOSITIONS OF RAPAMYCIN ESTERS - A stable pharmaceutical compositions of Rapamycin Esters, in particular Rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid that is free of antioxidants and a process of preparing the same. | 12-08-2011 |
Rohini Khanna, Hyderabad IN
Saurabh Khanna, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20110211620 | SWITCHING BETWEEN TRANSMIT AND RECEIVE MODES IN A WIRELESS TRANSCEIVER - A wireless transceiver decodes a receive signal to extract data contained in the receive signal. A processing block contained in the wireless transceiver then initiates a power-ON of the transmit radio portions of the transceiver prior to initiating a power-OFF of the receive radio portions. The technique enables the transceiver to meet timing requirements when operating in environments that require an acknowledgement to be sent in response to receipt of data. | 09-01-2011 |
Saurabh Khanna, Laxmi Nagar IN
Patent application number | Description | Published |
---|---|---|
20100306764 | TECHNIQUES FOR MANAGING VIRTUAL MACHINE (VM) STATES - Techniques for managing virtual machine (VM) states are provided. Applications executing within a processing context of a VM communicate outside that processing context with a hypervisor or VM Monitor (VMM) to have the hypervisor perform host operations for the VM. | 12-02-2010 |
Saurabh Khanna, Delhi IN
Patent application number | Description | Published |
---|---|---|
20130247035 | TECHNIQUES FOR MANAGING VIRTUAL MACHINE (VM) STATES - Techniques for managing virtual machine (VM) states are provided. Applications executing within a processing context of a VM communicate outside that processing context with a hypervisor or VM Monitor (VMM) to have the hypervisor perform host operations for the VM. | 09-19-2013 |
20150097729 | METHOD AND APPARATUS FOR GNSS SIGNAL TRACKING - A GNSS receiver to track low power GNSS satellite signals. The GNSS receiver includes a frequency locked loop (FLL) that measures a current doppler frequency of the satellite signal. A delay locked loop (DLL) measures a current code phase delay of the satellite signal. A current operating point corresponds to the current doppler frequency and the current code phase delay of the satellite signal. A grid monitor receives the satellite signal and the current operating point, and measures a satellite signal strength at a plurality of predefined offset points from the current operating point. The FLL and the DLL are centered at the current operating point. A peak detector is coupled to the grid monitor and processes the satellite signal strengths at the plurality of predefined offset points and re-centers the FLL and the DLL to a predefined offset point with the satellite signal strength above a predefined threshold. | 04-09-2015 |
20150185316 | TECHNIQUES FOR ANGLE RESOLUTION IN RADAR - A radar apparatus for estimating position of a plurality of obstacles. The radar apparatus includes a receive antenna unit. The receive antenna unit includes a linear array of antennas and an additional antenna at a predefined offset from at least one antenna in the linear array of antennas. The radar apparatus also includes a signal processing unit. The signal processing unit estimates an azimuth frequency associated with each obstacle of the plurality of obstacles from a signal received from the plurality of obstacles at the linear array of antennas. In addition, the signal processing unit estimates an azimuth angle and an elevation angle associated with each obstacle from the estimated azimuth frequency associated with each obstacle. | 07-02-2015 |
Sidharth Khanna, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20150262279 | ONE VIEW USER INTERFACE - A one view user interface for enabling prolific viewing of products and related information is described. The one view system user interface includes: a consolidated view of supplier, category or business unit on one platform encompassing information about its spend, contracts, supplier performance programs, sourcing events and purchase orders/invoices in order to enable the user to view information pertaining to supplier, category or business unit. The system avoids the user having to log in into different product portals to view related information or data, thereby helping the user to know the supplier related information while remaining in any one of the procurement tools and the user is not required to switch over from one product to another product. | 09-17-2015 |
20160019635 | ONE VIEW USER INTERFACE - A one view user interface system for enabling prolific viewing of products and related information is described. The one view system user interface includes: a consolidated view of supplier, category or business unit on one platform encompassing information about its spend, contracts, supplier performance programs, sourcing events and purchase orders/invoices in order to enable the user to view information pertaining to supplier, category and/or business unit. The system avoids the user having to log in into different product portals to view related information or data, thereby helping the user to know the supplier related information while remaining in any one of the procurement tools and the user is not required to switch over from one product to another product. | 01-21-2016 |
Smriti Khanna, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20150119394 | Insulin-Like Growth Factor-1 Receptor Inhibitors - The present invention relates to compounds that are capable of inhibiting, modulating and/or regulating Insulin-Like-Growth Factor I Receptor and Insulin Receptor. The compounds of the instant invention possess a core structure that comprises a sulfonyl indole moiety. The present invention is also related to the pharmaceutically acceptable salts, hydrates and stereoisomers of these compounds. | 04-30-2015 |
Varun Khanna, Pune IN
Patent application number | Description | Published |
---|---|---|
20140304365 | SYSTEM AND METHOD FOR KEYWORD-BASED NOTIFICATION AND DELIVERY OF CONTENT - System and method to provide keyword-based notification and content, the method including: monitoring a communication interface, the communication interface configured to transport a communication between an agent and a customer; recognizing, by use of a processor, a candidate keyword in the communication; retrieving, from a non-volatile data storage, an information related to the keyword; and presenting to one of the agent and the customer the information related to the keyword. | 10-09-2014 |
Venkatesh A. Khanna, Bavdhan IN
Patent application number | Description | Published |
---|---|---|
20150045115 | OPT-IN PROXIMITY ALERT - A method for alerting a player about a wagering game machine is described herein. In some embodiments, the method can include receiving, via a communications network from a handheld computing device, player preferences for an opt-in proximity alert. The method can further include creating the opt-in proximity alert based, at least in part, on the player preferences. The method can further include determining, via one or more processors, that the handheld computing device is in proximity to a wagering game machine matching the player preferences. The method can further include causing the handheld computing device to present an alert about the wagering game machine matching the player preferences. | 02-12-2015 |
Venkatesh A. Khanna, Pune IN
Patent application number | Description | Published |
---|---|---|
20140171206 | OPT-IN PROXIMITY ALERT - A method for alerting a player about a wagering game machine is described herein. In some embodiments, the method can include determining that a wagering game machine is in proximity to the handheld computing device. The method can further include indicating that the wagering game machine is in proximity to the handheld computing device. | 06-19-2014 |
Vimal Kumar Khanna, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20130246164 | SYSTEM AND METHOD FOR PREDICTING SPECIFIC MOBILE USER/SPECIFIC SET OF LOCALITIES FOR TARGETING ADVERTISEMENTS. - A method for predicting specific mobile users for targeting advertisements, the said method comprising: selecting at least one subset of mobile users subscribing to number of mobile services; creating and initializing subscribers attribute list and subscriber prediction table, based on their demographic details; monitoring the response & behavioral pattern of the mobile users of the subset based on the advertisements sent randomly throughout the day; populating the attribute list and prediction table based on the response information received from the mobile users; formulating a prediction-delivery matrix to identify the preferences of the mobile users for serving advertisements based on the populated attribute list & prediction table; generating a preference information of the mobile users of the subset based on the formulated matrix; extrapolating the generated preference information to the rest of the mobile user subscribers; and mining the mobile users data based on the extrapolated preference information for identifying specific user group for transmitting an advertisement. | 09-19-2013 |
Vinay Khanna, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20140089619 | OBJECT REPLICATION FRAMEWORK FOR A DISTRIBUTED COMPUTING ENVIRONMENT - A device may receive information that identifies a data item and a data item operation. The device may store a first sequence identifier, a data item reference that references the data item, and an operation reference that references the operation. The first sequence identifier may reference the data item and operation references, and may indicate an order in which the first sequence identifier is stored. The device may store the data item in a memory location, may store an identification of the memory location, may remove a reference to the data item by a previous sequence identifier, and/or may add the data item, may modify the data item, or may delete the data item depending on whether the operation is an add operation, a modify operation, or a delete operation. The device may transmit, to a slave device, the first sequence identifier, the data item reference, and the operation reference. | 03-27-2014 |
Vinay K. Khanna, Lucknow IN
Patent application number | Description | Published |
---|---|---|
20150224157 | PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS - The present invention relates to novel use of the extracts of | 08-13-2015 |
Vinay Kumar Khanna, Lucknow IN
Patent application number | Description | Published |
---|---|---|
20120184576 | ANTIPSYCHOTIC AGENTS AND STANDARDIZED ANTIPSYCHOTIC FRACTIONS FROM RAUWOLFIA TETRAPHYLLA AND PROCESS OF THEIR ISOLATION - The present invention relates to bioactive extracts its fractions and isolation of compound from | 07-19-2012 |
20120219649 | PROCESS FOR THE PREPARATION OF HERBAL EXTRACT OF CASSIA TORA LEAVES FOR TREATING ANXIETY DISORDERS - The present invention relates to novel use of the extracts of | 08-30-2012 |
20130184462 | METHOD FOR PREDICTING AND MODELING ANTI-PSYCHOTIC ACTIVITY USING VIRTUAL SCREENING MODEL - The present invention relates to the development of a virtual screening model for predicting antipsychotic activity using quantitative structure activity relationship (QSAR), molecular docking, oral bioavailability, ADME and Toxicity studies. The present invention also relates to the development of QSAR model using forward stepwise method of multiple linear regression with leave-one-out validation approach. QSAR model showed activity-descriptors relationship correlating measure (r | 07-18-2013 |
Vinod Kumar Khanna, Pilani IN
Patent application number | Description | Published |
---|---|---|
20100147683 | NOVEL POTENTIOMETRIC CHOLESTEROL SENSOR FOR THE QUANTITATIVE ESTIMATION OF TOTAL CHOLESTEROL IN HUMAN BLOOD SERUM - The present invention provides a novel sensor for the estimation of total cholesterol in human blood serum using molecular imprint of cholesterol. Human blood serum contains 150-250 mg/dl cholesterol. The present invention provides a sensor device and a process for the fabrication of ISFET (Ion Selective Field Effect Transister) coated with molecular imprint of cholesterol on the SiO | 06-17-2010 |
Vivek Khanna, Lucknow IN
Patent application number | Description | Published |
---|---|---|
20130338193 | CHIRAL 1-(4-METHYLPHENYLMETHYL)-5-OXO--PYRROLIDINE-2-CARBOXAMIDES AS INHIBITORS OF COLLAGEN INDUCED PLATELET ACTIVATION AND ADHESION - Chiral 1-(4-methylphenylmethyl)-5-oxo-{N-[(3-t-butoxycarbonyl-aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamides as inhibitors of collagen induced platelet activation and adhesion The present invention provides chiral (2S)-1-(4-methyl-phenylmethyl)-5-oxo-(3S)-{N-[(3-t butoxycarbonyl aminomethyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamide, and (2S)-1-(4-methylphenylmethyl)-5-oxo-(3R)-{N-[(3-t-butoxycarbonyl amino methyl)]-piperidin-1-yl}-pyrrolidine-2-carboxamide of formula 6 and 7 respectively. The present invention also relates to use of these moieties as inhibitors of collagen induced platelet adhesion and aggregation mediated through collagen receptors. The present invention provides a process for preparation of chiral carboxamides of formula 6 and 7 using the process which has advantage to avoid any racemization at the a-carboxylic center, during N-alkylation. The reagent LiHMDS is used at low temperatures to furnish methyl N-(p methylphenylmethyl)lpyroglutamate in good chiral purity. | 12-19-2013 |